Corinne Breque

Title: Corinne Breque: Innovator in Interleukin-7 Polypeptides

Introduction

Corinne Breque is a notable inventor based in Vanves, France. She has made significant contributions to the field of biotechnology, particularly in the development of interleukin-7 polypeptides. With a total of three patents to her name, her work focuses on improving therapeutic applications for mammalian subjects.

Latest Patents

Corinne's latest patents include innovative compositions related to hyperglycosylated mammalian IL-7 IgG conjugates. The first patent describes new and improved interleukin-7 polypeptides, emphasizing their preparation and therapeutic uses. These hyperglycosylated IL-7 polypeptides exhibit enhanced properties, making them valuable for curative or preventive treatments. The invention also introduces novel IL-7 polypeptides with modified amino acid sequences that contain artificially created glycosylation sites, along with corresponding nucleic acid molecules, vectors, and recombinant host cells.

Career Highlights

Corinne Breque is currently associated with Cytheris, a company dedicated to advancing biopharmaceuticals. Her work has been instrumental in developing therapies that leverage the unique properties of interleukin-7, contributing to advancements in medical treatments.

Collaborations

Corinne collaborates with esteemed colleagues, including Michel Christian Morre and Brigitte Assouline. Their combined expertise enhances the innovative research and development efforts within their field.

Conclusion

Corinne Breque stands out as a pioneering inventor in the realm of interleukin-7 polypeptides, with her patents paving the way for new therapeutic possibilities. Her contributions to biotechnology continue to impact the medical field positively.